MRVT — Miravant Medical Technologies Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Miravant Medical Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2000 December 31st | 2001 December 31st | 2002 December 31st | 2003 December 31st | 2004 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -26 | -16.4 | -16 | -7.46 | -15.9 |
Depreciation | |||||
Non-Cash Items | 7.31 | 4.45 | 2.68 | -4.15 | 4.18 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 3.57 | -4.49 | 3.82 | 0.241 | -0.069 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -13.4 | -15.2 | -8.57 | -10.8 | -11.5 |
Capital Expenditures | -0.462 | -0.354 | -0.154 | -0.306 | -0.323 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -15.3 | 15.1 | 4.72 | 1.62 | -2.98 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -15.8 | 14.8 | 4.57 | 1.31 | -3.3 |
Financing Cash Flow Items | 0 | -0.3 | -0.155 | -0.314 | 0.108 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 11.9 | 0.015 | 3.26 | 9.82 | 16.9 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -17.2 | -0.477 | -0.735 | 0.307 | 2.08 |